IAGS (International Andreas Gruentzig Society) Proceedings

My History of Carotid Angioplasty and Stenting

Jacques Théron, MD
Jacques Théron, MD

_______________________________________________

J INVASIVE CARDIOL 2008;20;E102-E108


My mentor, René Djindjian, one of the fathers of interventional neuroradiology, used to say that it was very difficult to write the history of a technique because one can never satisfy everyone. I agree, thus I will only present here the history of the endovascular treatment of carotid bifurcations based upon my personal experience and my view of its future evolution.
After the fundamental work in endovascular therapy by Charles Dotter1 and Andreas Grüntzig,2 it was inconceivable at the end of the 1970s to apply their work to arteries supplying the brain. Klaus Mathias chose to ignore this strict limit and was able to successfully perform angioplasty of atherosclerotic stenoses at the carotid bifurcation in 1980.3,4
We were not aware of Klaus Mathias’s breakthrough when, in 1980, we performed angioplasty of a subclavian artery (Figure 1). In the professional environment of the time, this case appeared extremely risky and my behavior unconventional. From 1980 to 1982, we did not risk approaching atherosclerotic stenoses at the carotid bifurcation because of frequent plaque ulceration at this level. We did, however, continue to perform a series of subclavian and vertebral angioplasty procedures.5 In 1981, we thought we had performed the first inversion of a subclavian steal syndrome (Figure 2), but later discovered that Bachman in Canada had already published his work on this topic.6

From 1981 on, along with others in the field, we began performing angioplasty of nonatherosclerotic stenoses at the carotid bifurcation such as fibromuscular dysplasias,7,8 inflammatory stenoses,9,10 post endarterectomy restenoses,11 post radiotherapy stenoses,12 as well as several cases of atherosclerotic stenoses of the external carotid artery.13 These cases appeared less risky to us.
We did not approach the treatment of atherosclerotic stenoses of the internal carotid artery before 1982, at which time we performed a series of 38 cases. In this first series, there were 5% dissections and 8% embolic complications that were fairly severe. The last embolic complication of this series occurred on an apparently very simple stenosis (Figure 3), but this case ended with a complication of scotoma from which the patient did not recover. It was a shock for me because it appeared obvious that it was impossible to routinely treat carotid atherosclerotic stenoses without facing risks that we could not control.

At this time, interventional neuroradiologists, following the work of Serbinenko in Russia, were often using all types of balloons. I was working at the Neurological Institute McGill University of Montreal, and had described and published a technique, still currently used, of embolization of vascular malformations of the face14 (Figure 4) and of the spinal cord15 (Figure 5), incorporating cerebral protection by temporary occlusion of the distal internal carotid or the vertebral artery. The idea to use temporary occlusion of the distal internal carotid artery in angioplasty of the carotid bifurcation was a direct consequence of this work.
 
We performed the first case of protected angioplasty of an ulcerated atherosclerotic stenosis in Montreal in 1984 (Figure 6). This first case used 2 catheters, an angioplasty catheter and a guiding catheter containing a microcatheter with an attached distal occlusive balloon (Figure 7). The angioplasty was achieved by ballooning over the microcatheter, and the potentially detached atherosclerotic particles were aspirated via the guiding catheter. At the same time, Jiri Vitek, another neuroradiologist, had successfully performed angioplasty of the innominate artery using cerebral protection by placing a balloon at the origin of the common carotid artery.16 Like our embolization technique, it actually involved protection only of the carotid supply, which was accomplished by capturing the particles that were potentially detached and headed toward the subclavian artery, but the vertebral artery supply remained unprotected, as particle capture was not possible. We now know that the potential risk of treating an innominate artery without protection is no higher than treating the subclavian artery, but this case is a good example of neuroradiologists’ concern at the time for protecting the brain.  

In 1986 we succeeded in concentrating the cerebral protective material in a single triple-coaxial catheter (Figure 8) using various materials that originally required a 2-meter long microcatheter.17 This concept was subsequently incorporated into the PercuSurge GuardWire® (PercuSurge, Inc., Minneapolis, Minnesota) (Figure 9) and other similar systems.
We were also interested, at the end of the 1980s, in the possibility of using temporary occlusion of the common carotid artery, but quickly realized that this entailed an inversion of the flux in the external carotid artery, and particularly in the occipital artery. The consequence was that the internal carotid artery continued to be supplied despite the occlusion of the common carotid artery. Thus, temporary occlusion did not protect the cerebral circulation. We published the images (Figures 10 and 11) from an experiment performed in 1987 showing the inversion of the flux in the external carotid in a letter18 commenting on the works of Kachel,19 who used this temporary occlusion technique alone as cerebral protection.
To improve the technique of temporary occlusion of the common carotid artery, in 1989 we performed several temporary occlusions of the common carotid artery along with simultaneous temporary occlusion of the origin of the external carotid artery (Figure 12). We presented these cases (Figure 13) at several international conventions including the Andreas Grüntzig Society meeting in Sydney in 1994, but did not publish them. They probably, at least partially, inspired the work by Juan Parodi.20 We abandoned work on this system because we considered it too complex compared to temporary occlusion of the distal internal carotid artery. Although this system is currently sold by two companies, we personally see it as best employed exclusively for the treatment of total occlusions of the internal carotid artery.

As for carotid endarterectomy, the question remains open as to who was the author of the first carotid stent case — Klaus Mathias or myself. What is most important is that the stent is now among the various therapeutic tools for the treatment of carotid bifurcations. How did I decide in 1990 to implant the first carotid stent, a case which was subsequently published?21 The patient was a 64-year-old female who had presented a few weeks previously with a clinically regressive brain infarction. She had a tight and irregular stenosis of the left internal carotid artery (Figures 14 and 15). We performed balloon-protected angioplasty in which the morphological result was unsatisfactory. Our experience had already shown us that this kind of result entailed rapid restenosis. Because the patient had already presented with a brain infarction, we decided to implant a Strecker stent (Boston Scientific Corp., Natick, Massachusetts)22 in the carotid artery without cerebral protection. Intuitively, we positioned the stent so as to cover the origin of the external carotid artery. As expected, my vascular surgeons colleagues confirmed that I was insane and had taken an enormous risk putting a foreign body in an artery supplying the brain. The patient subsequently showed no restenosis or new neurological symptoms. She agreed to undergo follow-up angiography 5 years later.
We believe that cerebral protection and stents are the two major advances that have permitted physicians to seriously consider an endovascular approach as an alternative in the treatment of the atherosclerotic stenoses at the carotid bifurcation because they have eliminated dissection complications and significantly reduced embolic complications.
The 1994 Andreas Gruntzig Society meeting held in Sydney was another milestone because we were able to present our work on the various types of carotid endovascular treatments, cerebral protection and stenting. This meeting was the true beginning of Gary Roubin’s interest23,24 in treating carotid arteries. His position as an eminent cardiologist in the United States, and even more importantly, his charisma, helped spread these techniques throughout the world. Neither Klaus Mathias nor myself would have been able to succeed alone given our European radiological backgrounds.

Numerous authors have subsequently worked on carotid endovascular therapy, but I would like to emphasize the role played by Nick Hopkins for two reasons. First, his research on cerebral protection systems using filters has been very important, even though we are not completely convinced that this is the ideal protection system, as will be seen below. His other major contribution has been to reposition, with his reputation of neurosurgeon using both endovascular and endarterectomy25 and his wide neurological background, the discussions away from the usual basic corporatist point of view.
As others did, we published our experience on our angioplasty with stenting and on cerebral protection.26,27 Nevertheless, I remain convinced that this technique is not completely developed. The main points of the debate and the future directions as I see them are as follow:
1) On a technical level we know that cerebral protection is necessary.28,29 Since the first balloon angioplasty procedures, we know that angioplasty without protection and without stent placement is associated with a 5% dissection rate and a 5–10% embolic complication rate. The stent has eliminated the dissection complications. The discussion persists as to which are the best cerebral protection systems.
Although attractive, is the filter the perfect answer? Probably not. All protective techniques are partial, and what is most important is to select the one that offers minimum risk and ease-of-use. The filter does not protect against clots or particles upon passage of the stenosis, it does not protect from particles smaller than the pores of the filter, and most notably, it does not protect against “shower” embolisms. Finally, the filter itself can sometimes generate more embolic complications than does unprotected angioplasty.30,31
We personally continue to think that the best protection is provided by temporary occlusion of the distal internal carotid artery on condition that the occlusion is efficient. This was not always achieved with the early commercial systems. Our experience has brought us to reconsider cerebral protection (Figures 16 results32 confirm our technical options. We base this on a certain number of points: (a) the carotid sinus represents a natural filter that entails regrouping of the atherosclerotic deposits at the origin of the internal carotid artery; (b) the only step of the procedure that presents a meaningful embolic risk is postdilatation, when the plaque is broken; (c) with the new stent profiles, predilatation is rarely necessary (< 5%); when predilatation is necessary, it must be performed with a small-diameter (2 mm) balloon that will allow passage of the stent, and definitely not with a 3 or 4 mm balloon that could cause plaque rupture, rapid platelet aggregation and increase the risk of embolism at the site of stent deployment; (d) long stents (4–5 cm) do not increase the risk of restenosis at the level of the carotid bifurcation and they treat the entire lesion (Figure 18).
2) In practice, we believe that many of the impossibilities and complications related to endovascular carotid treatment are due to vascular approach problems. It is for this reason that we developed the radial approach,33 which solves the problem of difficult femoral approach cases and completes our therapeutic tool options (Figures 19 and 20).

3) Carotid endovascular treatment is a technique that is undergoing both technical evolution and diversification. Today’s operators now come from various specialties (vascular radiologists, neuroradiologists, vascular surgeons, neurosurgeons, cardiologists). The first protocols compared it with endarterectomy, which was considered a relatively mature procedure. It is important to remember that NASCET (North American Symptomatic Carotid Endarterectomy Trial),34 which established the benefit of endarterectomy versus medical treatment, involved selected patients who were operated on by trained surgeons, and was the first positive study after two similar unfavorable studies. The major difference between NASCET and these negative studies is that the carotid surgery had not been interrupted. On the contrary, the unfavorable results of the EVA 3S35 study, in which many elements could be easily contested, has totally halted the use of endovascular therapy in France, with the exception of high-risk surgical cases.
4) We are convinced that supra-aortic endovascular treatment holds great potential for the future, not only in symptomatic carotid stenoses, but also in so-called asymptomatic stenoses that are responsible for cerebral vascular insufficiency. These latter are due to the hemodynamic summation of several moderate stenoses simultaneously reducing flow in several arteries supplying the brain, which leads to a loss of cerebral vascular reserve and significant changes in cognitive function (Figure 21). Considering the aging population, this group of patients is becoming increasingly important.36

 

References

References

1. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: Description of a new technique and a preliminary report of its applications. Circulation 1964;30:654–670.
2. Grüntzig A, Hopf H. Perkutane Rekanalisation chronischer arterieller verschlüsse mit einem neuen katheter: Modifikation der Dottrer-technik. Deutsch Med Wochenschr 1974;99:2502–2505.
3. Mathias K. Perkutane transluminale Katheterbehhandlung supraaortaler Arterienobstruktionen. Angiology 1981;3:47–50.
4. Bockenheimer SA, Mathias K. Percutaneous transluminal angioplasty in arteriosclerotic internal carotid stenosis. Am J Neuroradiol 1983;4:791–792.
5. Théron J, Courtheoux P, Henriet JP, et al. Angioplasty of supraaortic arteries. J Neuroradiology 1984;11:187–200.
6. Bachman DM, Kim RM. Transluminal dilatation for subclavian steal syndrome. Am J Radiol 1980;136:995–996.
7. Garrido E, Montoya J. Transluminal dilatation of internal carotid artery in fibromuscular dysplasia: A preliminary report. Surg Neurol 1981;16:469–471.
8. Hasso AN, Bird CR, Zinke DE, Thomson JR. Fibromuscular dysplasia of the internal carotid artery: Percutaneous transluminal angioplasty. Am J Radiol 1981;136:955–960.
9. Hodgins GW, Dutton JW. Subclavian and carotid angioplasties for Takayazshu’s arteritis. J Can Assoc Radiol 1982;33:205–207.
10. Théron J, Tyler JL. Takayasu’s arteritis of the aortic arch: Endovascular treatment and correlation with positron emission tomography. Am J Neuroradiol 1987;8:621–626.
11. Théron J, Raymond J, Casasco A, Courtheoux F. Percutaneous angioplasty of atherosclerotic and post-surgical stenosis of carotid arteries. Am J Neuroradiol 1987;8:495–500.
12. Guthaner DF, Schmidt L. Percutaneous transluminal angioplasty of radiation induced arterial stenoses. Radiology 1982;144:77–78.
13. Vitek JJ, Morawetz RB. Percutaneous transluminal angioplasty of the external carotid artery: Preliminary report. Am J Neuroradiol 1982;3:541–546.
14. Théron J, Cosgrove R, Melançon D, Ethier R. Embolization with temporary balloon occlusion of the internal carotid and vertebral arteries. Neuroradiology 1986;28:246–253.
15. Théron J, Cosgrove R, Melançon D, Ethier R. Advances in the embolization of spinal arteriovenous malforamtions. Radiology 1986;158:163–169.
16. Vitek JJ, Raymon BC, Oh SJ. Innominate artery angioplasty. Am J Neuroradiol 1984;5:113–114.
17. Théron J, Courtheoux P, Alachkar F, Maiza D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. Am J Neuroradiol 1990;11:869–874.
18. Théron J. Cerebral protection during carotid angioplasty. J Endovasc Surg 1996;3:484–485.
19. Kachel R. Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 1996;3:226–230.
20. Parodi JC, Fereira LM. Cerebral protection during carotid stenting using flow reversal. J Vasc Surg 2005;41:416–422.
21. Théron J. Angioplasty of brachiocephalic vessels. In: Interventional Neuroradiology: Endovascular Therapy of the Central Nervous System. (Vinuela F, et al. eds). Raven Press: New York, 1992.
22. Strecker EP, Hagen B, Liermann D. Current status of the Strecker stent. Cardiol Clin 1994;12:673–687.
23. Roubin GS, Yadav S, Iyer SS, Vitek J. Carotid stent-supported angioplasty: A neurovascular intervention to prevent stroke. Am J Cardiol 1996;78(3A):8–12.
24. Roubin GS, Iyer SS, Vitek JJ, et al. Immediate and late outcome of carotid artery stenting in patients with symptomatic and asymptomatic carotid stenosis: A 5-year prospective analysis. Circulation 2001;103:532–537.
25. Hanel RA, Levy EI, Guterman LR, Hopkins LN. Carotid angioplasty with stenting and carotid endarterectomy: Both are here to stay. In: Horowitz MB, Levy EI (eds). Neuroendovascular Surgery. Basel: Karger, 2005, pp. 32–53.
26. Théron J, Payelle GC, Hu H, et al. Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement. Radiology 1996;201:627–636.
27. Theron J, Guimaraens L, Casasco A, et al. “Protected” wallstenting of atheromatous stenoses at the carotid bifurcation. Interv Neuroradiol 2003;9:99–126.
28. Macdonald S. The evidence for cerebral protection: An analysis and summary of the literature. Eur J Radiol 2006;60:20–25.
29. Martin JB, Pache JC, Treggiari-Venzi M, et al. Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke 2001;32:479–484.
30. Macdonald S. Thesis for the Degree of Philosophy: Neuroprotection and flow dynamics in carotid stenting. October 2004. University of Sheffield Main Library Volumes I & II 2004 [MO115661SH] Main Lib Thesis 12638.
31. Macdonald S, McKevitt F, Venables GS, et al. Neurological outcomes after carotid stenting protected with the NeuroShield filter compared to unprotected stenting. J Endovasc Ther 2002;9:777–785.
32. Théron J, Bedogni F, Venturi C, et al. Immediate and mid-term clinical outcome of patients treated with the “TwinOne” cerebral protection system. Communication at TCT meeting, Washington D.C., October 2007.
33. Théron J, Guimaraens L, Casasco A, et al. Radial approach in the treatment of supraaortic arterial lesions. Interv Neuroradiol 2007;13:133–144.
34. North American Symptomatic Carotid Endarterctomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients wth high grade stenosis. N Engl J Med 1991;325:445–453.
35. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660–1671,1726–1729.
36. Théron J, De Oliveira D, Alachkar F, Maiza D. Dynamic digitalized parenchymography. Neuroradiology 1992;34:361–364.